Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J T Brouwer

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
Digestive Diseases and Sciences|December 1, 1996
Interferon-ribavirin combination therapy for chronic hepatitis CS W Schalm, J T Brouwer, L Chemello, et al.
Journal of Clinical Epidemiology|May 30, 2001
A psychometric comparison of health-related quality of life measures in chronic liver diseaseG Unal, J B de Boer, G J Borsboom, et al.
Journal of Clinical Microbiology|February 1, 1994
Sequence analysis of the 5' untranslated region in isolates of at least four genotypes of hepatitis C virus in The NetherlandsG E Kleter, L J van Doorn, J T Brouwer, et al.
Journal of Gastroenterology and Hepatology|November 26, 1999
Intravenous glycyrrhizin for the treatment of chronic hepatitis C: a double-blind, randomized, placebo-controlled phase I/II trialT G van Rossum, A G Vulto, W C Hop, et al.
The Journal of General Virology|July 1, 1995
Sequence analysis of hepatitis C virus genotypes 1 to 5 reveals multiple novel subtypes in the Benelux countriesL J van Doorn, G E Kleter, L Stuyver, et al.
The British Journal of Dermatology|August 23, 2003
Hyperpigmentation during interferon-alpha therapy for chronic hepatitis C virus infectionM Willems, K Munte, J M Vrolijk, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 24, 2001
Safety of interferon and ribavirin therapy in haemodialysis patients with chronic hepatitis C: results of a pilot studyA C Tan, J T Brouwer, P Glue, et al.
Journal of Hepatology|May 1, 1997
Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C. Meta-analysis of individual patient data from European centersS W Schalm, B E Hansen, L Chemello, et al.
Journal of Medical Virology|September 1, 1995
Rapid genotyping of hepatitis C virus RNA-isolates obtained from patients residing in western EuropeG E Kleter, L J van Doorn, L Stuyver, et al.
Journal of Medical Virology|December 14, 1999
Long term response to interferon treatment in chronic hepatitis C patients is associated with a significant reduction in anti-E1 envelope antibody titersS Depraetere, E Van Kerschaever, H Van Vlierberghe, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Digestive Diseases and Sciences|December 1, 1996
Interferon-ribavirin combination therapy for chronic hepatitis CS W Schalm, J T Brouwer, L Chemello, et al.
Journal of Clinical Epidemiology|May 30, 2001
A psychometric comparison of health-related quality of life measures in chronic liver diseaseG Unal, J B de Boer, G J Borsboom, et al.
Journal of Clinical Microbiology|February 1, 1994
Sequence analysis of the 5' untranslated region in isolates of at least four genotypes of hepatitis C virus in The NetherlandsG E Kleter, L J van Doorn, J T Brouwer, et al.
Journal of Gastroenterology and Hepatology|November 26, 1999
Intravenous glycyrrhizin for the treatment of chronic hepatitis C: a double-blind, randomized, placebo-controlled phase I/II trialT G van Rossum, A G Vulto, W C Hop, et al.
The Journal of General Virology|July 1, 1995
Sequence analysis of hepatitis C virus genotypes 1 to 5 reveals multiple novel subtypes in the Benelux countriesL J van Doorn, G E Kleter, L Stuyver, et al.
The British Journal of Dermatology|August 23, 2003
Hyperpigmentation during interferon-alpha therapy for chronic hepatitis C virus infectionM Willems, K Munte, J M Vrolijk, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 24, 2001
Safety of interferon and ribavirin therapy in haemodialysis patients with chronic hepatitis C: results of a pilot studyA C Tan, J T Brouwer, P Glue, et al.
Journal of Hepatology|May 1, 1997
Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C. Meta-analysis of individual patient data from European centersS W Schalm, B E Hansen, L Chemello, et al.
Journal of Medical Virology|September 1, 1995
Rapid genotyping of hepatitis C virus RNA-isolates obtained from patients residing in western EuropeG E Kleter, L J van Doorn, L Stuyver, et al.
Journal of Medical Virology|December 14, 1999
Long term response to interferon treatment in chronic hepatitis C patients is associated with a significant reduction in anti-E1 envelope antibody titersS Depraetere, E Van Kerschaever, H Van Vlierberghe, et al.
Pageof 5